OPRX logo

OptimizeRx (OPRX)

Profile

Full Name

OptimizeRx Corporation

Ticker Symbol

OPRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

November 28, 2007

Indexes

Not included

Website

http://www.optimizerx.com

Employees

128

Key Details

Price

$8.18(-1.80%)

Market cap

$151.25M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$92.13M(+28.81% YoY)

Annual EPS

-$1.10(-6.80% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.18
OPRX price is $8.18

30-Day Relative Volume

0.11
OPRX 30-day relative volume is 0.11

Price Performance

Price Most recent change

-1.8%
OPRX price was down -1.8% on Apr 16, 2025

Price YTD change

+68.31%
OPRX price is up +68.31% since January 1st

Price 1-year change

-17.87%
OPRX price is down -17.87% year-on-year

Price 3-year change

-78.99%
OPRX price is down -78.99% over the past 3 years

Price Range

Price All-time high

$99.18
OPRX price is currently -91.75% below its historical high of $99.18

Price 3-year low

$3.78
OPRX price is currently +116.40% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$151.25M
OPRX market capitalization is $151.25 million

Market cap 3-year change

-78.6%
OPRX market capitalization is down -78.6% over the past 3 years

Market cap All-time high

$1.74B
OPRX market capitalization is currently -91.29% below its historical high of $1.74 billion

Market cap sector rank

53.7%
OPRX market capitalization is higher than 53.7% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.69%
OPRX shares outstanding is up +1.69% year-on-year

Shares Outstanding 3-Year Change

+1.86%
OPRX shares outstanding is up +1.86% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.45
OPRX beta is 1.45

200-day SMA

$6.95
OPRX price is currently +17.68% above its 200-day simple moving average

50-day SMA

$6.91
OPRX price is currently +18.38% above its 50-day simple moving average

RSI

55.15
OPRX 14-day relative strength index is 55.15

Volume

0.11
OPRX 30-day relative volume is 0.11

ATR

$0.71
OPRX average true range is $0.71

10-day Historical Volatility

76.33%
OPRX 10-day historical volatility is 76.33%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$92.13M
OPRX annual revenue is $92.13 million

Revenue Analysts estimate

$101.26M
OPRX annual revenue is currently -9.02% lower than the consensus analysts' forecast

Revenue 1-year change

+28.81%
OPRX annual revenue is up +28.81% year-on-year

Revenue Sector rank

55.75%
OPRX annual revenue is higher than 55.75% of companies in Healthcare sector

EPS

EPS

-$1.10
OPRX annual earnings per share is -$1.10

EPS Analysts estimate

$0.40
OPRX annual earnings per share is currently -377.99% lower than the consensus analysts' forecast

EPS 1-year change

-6.8%
OPRX annual earnings per share is down -6.8% year-on-year

EPS Sector rank

54.43%
OPRX annual earnings per share is higher than 54.43% of companies in Healthcare sector

Profit

Gross profit

$59.38M
OPRX annual gross profit is $59.38 million

Gross margin

64.45%
OPRX annual gross profit margin is 64.45%

Operating profit

-$6.22M
OPRX annual operating income is -$6.22 million

Operating margin

-6.75%
OPRX annual operating profit margin is -6.75%

Net income

-$20.11M
OPRX annual net profit is -$20.11 million

Net margin

-21.83%
OPRX annual net profit margin is -21.83%

Expenses

Total expenses

$98.34M
OPRX annual total expenses is $98.34 million

Operating expenses

$65.59M
OPRX annual total operating expenses is $65.59 million

Cost of goods sold

$32.75M
OPRX annual cost of goods sold is $32.75 million

Selling, general & administrative expenses

$61.27M
OPRX annual SGA is $61.27 million

Depreciation and amortization

$4.33M
OPRX annual depreciation & amortization is $4.33 million

Interest expense

$6.16M
OPRX annual interest expense is $6.16 million

Income tax

$725.00K
OPRX annual income tax is $725.00 thousand

EBIT & EBITDA

EBIT

-$13.22M
OPRX annual earnings before interest & taxes is -$13.22 million

EBITDA

-$8.90M
OPRX annual EBITDA is -$8.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$171.17M
OPRX annual total assets is $171.17 million

Non current assets

$117.20M
OPRX annual long term assets is $117.20 million

Current assets

$53.97M
OPRX annual total current assets is $53.97 million

Cash and cash equivalents

$13.38M
OPRX annual cash & cash equivalents is $13.38 million

Accounts receivable

$38.21M
OPRX annual accounts receivable is $38.21 million

Inventory

-
OPRX annual inventory value is unknown

Liabilities

Total liabilities

$54.17M
OPRX annual total liabilities is $54.17 million

Long term liabilities

$35.52M
OPRX annual total long term liabilities is $35.52 million

Current liabilities

$18.65M
OPRX annual total current liabilities is $18.65 million

Accounts payable

$2.16M
OPRX annual accounts payable is $2.16 million

Debt

Total debt

$33.19M
OPRX annual total debt is $33.19 million

Total debt 1-year change

-9.86%
OPRX annual total debt is down -9.86% year-on-year

Long term debt

$31.02M
OPRX annual long term debt is $31.02 million

Short term debt

$2.17M
OPRX annual short term debt is $2.17 million

Equity & Capital

Shareholders equity

$117.00M
OPRX annual stockholders equity is $117.00 million

Book value

$117.00M
OPRX annual book value is $117.00 million

Retained earnings

-$84.37M
OPRX annual retained earnings is -$84.37 million

Working capital

$35.32M
OPRX annual working capital is $35.32 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.89M
OPRX annual cash flow from operations is $4.89 million

Cash from operations 1-year change

+167.54%
OPRX annual cash flow from operations is up +167.54% year-on-year

Cash from investing

-$450.00K
OPRX annual cash flow from investing activities is -$450.00 thousand

Cash from investing 1-year change

+98.22%
OPRX annual cash flow from investing activities is up +98.22% year-on-year

Cash from financing

-$4.91M
OPRX annual cash flow from financing activities is -$4.91 million

Cash from financing 1-year change

-117.4%
OPRX annual cash flow from financing activities is down -117.4% year-on-year

CAPEX

CAPEX

$450.00K
OPRX annual capital expenditures is $450.00 thousand

CAPEX 1-year change

-48.36%
OPRX annual capital expenditures is down -48.36% year-on-year

Free Cash Flow

Free cash flow

$4.44M
OPRX annual free cash flow is $4.44 million

Free cash flow 1-year change

+154.73%
OPRX annual free cash flow is up +154.73% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

64.45%
OPRX annual gross profit margin is 64.45%

Operating margin

-6.75%
OPRX annual operating profit margin is -6.75%

Net margin

-21.83%
OPRX annual net profit margin is -21.83%

ROA & ROE

ROA

-11.34%
OPRX annual return on assets is -11.34%

ROE

-16.51%
OPRX annual return on equity is -16.51%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OPRX price to earnings ratio value is unknown

PE ratio Sector rank

-
OPRX price to earnings ratio is unknown

PB Ratio

PB ratio

1.29
OPRX price to book ratio is 1.29

PB ratio Sector rank

51.03%
OPRX price to book ratio is higher than 51.03% of companies in Healthcare sector

PS Ratio

PS ratio

1.64
OPRX price to sales ratio is 1.64

PS ratio Sector rank

38.85%
OPRX price to sales ratio is higher than 38.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$171.06M
OPRX enterprise value is $171.06 million

Enterprise value Sector rank

56.58%
OPRX enterprise value is higher than 56.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-19.24
OPRX EV/EBITDA is -19.24

EV/EBITDA Sector rank

6.09%
OPRX EV/EBITDA is higher than 6.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.89
OPRX annual current ratio is 2.89

Quick ratio

-
OPRX annual quick ratio value is unknown

Leverage

Debt to equity

0.28
OPRX annual debt to equity ratio is 0.28

Interest coverage ratio

-2.15
OPRX annual interest coverage ratio is -2.15

Risk & Stability

Piotroski F-Score

5
OPRX piotroski f-score is 5

Altman Z-Score

1.52
OPRX altman z-score is 1.52

Analyst ratings

Recent major analysts updates

Feb 6, 25 JMP Securities
Market Outperform
Jan 8, 25 RBC Capital
Sector Perform
Dec 24, 24 Lake Street
Buy
Dec 24, 24 B. Riley Securities
Buy
Dec 20, 24 Stephens & Co.
Equal-Weight
Nov 14, 24 Stifel
Buy
Nov 14, 24 Roth MKM
Buy
Nov 14, 24 RBC Capital
Outperform
Nov 14, 24 JMP Securities
Market Outperform
Nov 14, 24 Barclays
Equal-Weight

Institutional Ownership

Similar stocks

ACIU logo
AC Immune SA (ACIU)
JYNT logo
Joint (JYNT)
ARAY logo
Accuray Incorporated (ARAY)
DMAC logo
DiaMedica Therapeutics (DMAC)
STXS logo
Stereotaxis (STXS)
SGMO logo
Sangamo Therapeutics (SGMO)
EUDA logo
EUDA Health Holdings Limited (EUDA)
TARA logo
Protara Therapeutics (TARA)
NBTX logo
Nanobiotix SA (NBTX)
  • What is the ticker symbol for OptimizeRx?
  • Does OptimizeRx pay dividends?
  • What sector is OptimizeRx in?
  • What industry is OptimizeRx in?
  • What country is OptimizeRx based in?
  • When did OptimizeRx go public?
  • Is OptimizeRx in the S&P 500?
  • Is OptimizeRx in the NASDAQ 100?
  • Is OptimizeRx in the Dow Jones?
  • When was OptimizeRx's last earnings report?
  • When does OptimizeRx report earnings?
  • Should I buy OptimizeRx stock now?

What is the ticker symbol for OptimizeRx?

The ticker symbol for OptimizeRx is NASDAQ:OPRX

Does OptimizeRx pay dividends?

No, OptimizeRx does not pay dividends

What sector is OptimizeRx in?

OptimizeRx is in the Healthcare sector

What industry is OptimizeRx in?

OptimizeRx is in the Health Information Services industry

What country is OptimizeRx based in?

OptimizeRx is headquartered in United States

When did OptimizeRx go public?

OptimizeRx's initial public offering (IPO) was on November 28, 2007

Is OptimizeRx in the S&P 500?

No, OptimizeRx is not included in the S&P 500 index

Is OptimizeRx in the NASDAQ 100?

No, OptimizeRx is not included in the NASDAQ 100 index

Is OptimizeRx in the Dow Jones?

No, OptimizeRx is not included in the Dow Jones index

When was OptimizeRx's last earnings report?

OptimizeRx's most recent earnings report was on Mar 12, 2025

When does OptimizeRx report earnings?

The next expected earnings date for OptimizeRx is May 14, 2025

Should I buy OptimizeRx stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page